Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $40.7B |
| FY2017, ended Dec 31, 2017 | $42.3B |
| FY2018, ended Dec 31, 2018 | $39.2B |
| FY2019, ended Dec 31, 2019 | $47.0B |
| FY2020, ended Dec 31, 2020 | $45.6B |
| FY2021, ended Dec 31, 2021 | $48.2B |
| FY2022, ended Dec 31, 2022 | $45.8B |
| FY2023, ended Dec 31, 2023 | $40.9B |
| FY2024, ended Dec 31, 2024 | $43.5B |
| FY2025, ended Dec 31, 2025 | $33.5B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $36.5B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $18.3B |
| FY2017, ended Dec 31, 2017 | $18.3B |
| FY2018, ended Dec 31, 2018 | $18.5B |
| FY2019, ended Dec 31, 2019 | $18.4B |
| FY2020, ended Dec 31, 2020 | $19.1B |
| FY2021, ended Dec 31, 2021 | $19.4B |
| FY2022, ended Dec 31, 2022 | $20.2B |
| FY2023, ended Dec 31, 2023 | $17.1B |
| FY2024, ended Dec 31, 2024 | $16.8B |
| FY2025, ended Dec 31, 2025 | $16.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $16.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.17B | $2.46B |
| FY2017, ended Dec 31, 2017 | $2.28B | $2.14B |
| FY2018, ended Dec 31, 2018 | $1.41B | $2.09B |
| FY2019, ended Dec 31, 2019 | $2.16B | $1.53B |
| FY2020, ended Dec 31, 2020 | $2.35B | $2.51B |
| FY2021, ended Dec 31, 2021 | $1.81B | $1.72B |
| FY2022, ended Dec 31, 2022 | $1.93B | $1.86B |
| FY2023, ended Dec 31, 2023 | $1.76B | $2.78B |
| FY2024, ended Dec 31, 2024 | $2.54B | $2.51B |
| FY2025, ended Dec 31, 2025 | $2.02B | $1.64B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.96B | $1.82B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $923M |
| FY2017, ended Dec 31, 2017 | $616M |
| FY2018, ended Dec 31, 2018 | $539M |
| FY2019, ended Dec 31, 2019 | $442M |
| FY2020, ended Dec 31, 2020 | $303M |
| FY2021, ended Dec 31, 2021 | $270M |
| FY2022, ended Dec 31, 2022 | $427M |
| FY2023, ended Dec 31, 2023 | $1.09B |
| FY2024, ended Dec 31, 2024 | $1.01B |
| FY2025, ended Dec 31, 2025 | $688M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $956M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.57B |
| FY2017, ended Dec 31, 2017 | $7.42B |
| FY2018, ended Dec 31, 2018 | $7.46B |
| FY2019, ended Dec 31, 2019 | $7.75B |
| FY2020, ended Dec 31, 2020 | $8.36B |
| FY2021, ended Dec 31, 2021 | $8.57B |
| FY2022, ended Dec 31, 2022 | $8.42B |
| FY2023, ended Dec 31, 2023 | $7.98B |
| FY2024, ended Dec 31, 2024 | $7.42B |
| FY2025, ended Dec 31, 2025 | $7.17B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.52B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 6.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 356M |
| FY2017, ended Dec 31, 2017 | 351M |
| FY2018, ended Dec 31, 2018 | 344M |
| FY2019, ended Dec 31, 2019 | 342M |
| FY2020, ended Dec 31, 2020 | 338M |
| FY2021, ended Dec 31, 2021 | 337M |
| FY2022, ended Dec 31, 2022 | 338M |
| FY2023, ended Dec 31, 2023 | 337M |
| FY2024, ended Dec 31, 2024 | 332M |
| FY2025, ended Dec 31, 2025 | 332M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 333M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $739M | $77.0M |
| FY2017, ended Dec 31, 2017 | $911M | $76.0M |
| FY2018, ended Dec 31, 2018 | $800M | $41.0M |
| FY2019, ended Dec 31, 2019 | $800M | $96.0M |
| FY2020, ended Dec 31, 2020 | $700M | $147M |
| FY2021, ended Dec 31, 2021 | $400M | $26.0M |
| FY2022, ended Dec 31, 2022 | $100M | $150M |
| FY2023, ended Dec 31, 2023 | $225M | $169M |
| FY2024, ended Dec 31, 2024 | $1.00B | $131M |
| FY2025, ended Dec 31, 2025 | $141M | $140M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $21.0M | $131M |
Valuation
At current price- Market Cap
- $36.3B
- P/E
- 18.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.2×
- Price / Book
- 20.7×
- EV / EBITDA
- 12.9×
Growth
Trailing 12 months- Revenue (TTM)
- $16.6B
- Revenue Growth YoY
- 0.7%
- Revenue CAGR 3Y
- −6.6%
- Revenue CAGR 5Y
- −3.0%
- EPS Growth YoY
- −19.1%
- Net Income Growth YoY
- −19.5%
Profitability
Trailing 12 months- Gross Margin
- 36.8%
- Operating Margin
- 15.2%
- Net Margin
- 11.8%
- FCF Margin
- 11.0%
- Return on Equity
- 129%
Earnings
Trailing 12 months- Net Income
- $1.96B
- EPS (diluted)
- $5.87
- EBITDA
- $3.24B
- Operating Income
- $2.51B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $956M
- Total Debt
- $6.52B
- Net Debt
- $5.56B
- Total Assets
- $18.6B
- Total Liabilities
- $16.7B
- Shareholders' Equity
- $1.75B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.33B
- Capital Expenditure
- $1.51B
- Free Cash Flow
- $1.82B
Dividends and risk
Last 12 months- Dividend Yield
- 4.7%
- Dividend / Share
- $5.10
- Beta (5Y)
- 0.25
Every ratio is calculated from the company’s reported figures.